X4 Pharmaceuticals Secures Up to $150 Million Debt Facility
X4 Pharmaceuticals has secured a senior secured term loan facility of up to $150 million from K2 HealthVentures. This new financing replaces the company's previous loan agreement and offers greater financial flexibility as it advances its drug development programs. The first tranche of $80 million was funded at closing, providing immediate liquidity for X4 Pharmaceuticals' operations and research initiatives. The deal is expected to support ongoing clinical trials and potentially reduce reliance on equity financing in the near term.
